EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TNF / TNFR1 is a Key Regulator of Prolonged Fasting‐Induced Decrease in Adipose Tissue

Amanda Carla Clemente de Oliveira, Adma Maciel Babêtto, Mariele Lino Silva, Larisse de Souza Barbosa Lacerda, Thiago de Souza Rodrigues, Marina Chaves de Oliveira, Christine Rouault, Emmanuel L Gautier, André Gustavo Oliveira, Karine Clément, Mauro Martins Teixeira, Geneviève Marcelin und 1 weitere

The FASEB Journal · 2026

DOI: 10.1096/fj.202501928rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Amanda Carla Clemente de Oliveira und 12 weiteren Autor:innen. Beteiligte Einrichtung: Immunometabolism, Department of Nutrition, Nursing School, Federal University of Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type I, Fasting, Tumor Necrosis Factor-alpha, Adipose Tissue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Instituto Nacional de Ciência e Tecnologia de Nanobiofarmacêutica (INCT NanoBiofar).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nutrient availability influences white adipose tissue (WAT) inflammation, leading to decreased or increased adiposity. Tumor necrosis factor (TNF) is elevated in WAT under both conditions, being involved in lipolysis and regulation of interleukin 18 (IL‐18) secretion, which may regulate lipolytic processes. However, the role of these cytokines in adiposity reduction due to low energy availability remains unclear. Wild‐type (WT) mice fasted for 24 h showed decreased adiposity, whereas TNFR1 knockout mice (TNFR1 −/− ) were unresponsive to fat pad loss, even after 48‐h fasting. TNFR1 −/− mice were also resistant to β 3‐adrenergic receptor agonist CL316,243‐induced fat mobilization, which was linked with reduced expression of lipases, β 3‐adrenergic receptors, and cytokines in WAT. Also, mice treated with the TNF‐α inhibitor infliximab and fasted for 48 h showed resistance to adiposity loss, suggesting that prolonged fasting‐induced TNF signaling may modulate adipose tissue reduction. Conversely, IL‐18 does not seem to influence fat pad loss induced by 24‐h fasting as IL‐18 knockout mice (IL‐18 −/− ) express TNF in WAT and respond to prolonged fasting similarly to WT animals. To assess the potential translational relevance of our findings to human obesity, we analyzed 53 samples from patients with obesity who underwent bariatric surgery. Interestingly, TNFR1 and IL‐18 expressions in sWAT correlate with the expression of lipases and adipokines in the subcutaneous site despite no correlation with body weight or fat mass 1 year after surgery. In summary, this study suggests that the TNF/TNFR1 axis is crucial for metabolic adaptation and is a prerequisite for prolonged fasting‐induced lipolysis in male mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Tumor Necrosis Factor, Type IFastingTumor Necrosis Factor-alphaAdipose TissueAdipose Tissue, WhiteAnimalsMiceMice, KnockoutMaleMice, Inbred C57BLLipolysisAdiposityInterleukin-18

Stichwörter der Autor:innen

Interleukin‐18adipose tissuebariatric surgeryprolonged fastingtumor necrosis factor

Substanzen

Receptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alphaTnfrsf1a protein, mouseInterleukin-18

Autor:innen und Institutionen

  • Immunometabolism, Department of Nutrition, Nursing School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Drug Research and Development Center, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • INSERM, Nutrition and Obesities: Systemic Approach Research Group, Nutriomics, Sorbonne University, Paris, France.
  • Computer Department, Federal Center for Technological Education of Minas Gerais, Belo Horizonte, Brazil.
  • Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Brazil.

ORCID-Profile: Adaliene Versiani Matos Ferreira

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
  • Instituto Nacional de Ciência e Tecnologia de Nanobiofarmacêutica (INCT NanoBiofar)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Zitieren

APA

de Oliveira, A. C. C., Babêtto, A. M., Silva, M. L., de Souza Barbosa Lacerda, L., de Souza Rodrigues, T., de Oliveira, M. C., Rouault, C., Gautier, E. L., Oliveira, A. G., Clément, K., Teixeira, M. M., Marcelin, G., & Ferreira, A. V. M. (2026). TNF / TNFR1 is a Key Regulator of Prolonged Fasting‐Induced Decrease in Adipose Tissue. The FASEB Journal. https://doi.org/10.1096/fj.202501928rr

Vancouver

de Oliveira ACC, Babêtto AM, Silva ML, de Souza Barbosa Lacerda L, de Souza Rodrigues T, de Oliveira MC, et al. TNF / TNFR1 is a Key Regulator of Prolonged Fasting‐Induced Decrease in Adipose Tissue. The FASEB Journal. 2026. doi:10.1096/fj.202501928rr

BibTeX
@article{deOliveira2026,
  author = {de Oliveira, Amanda Carla Clemente and Babêtto, Adma Maciel and Silva, Mariele Lino and de Souza Barbosa Lacerda, Larisse and de Souza Rodrigues, Thiago and de Oliveira, Marina Chaves and Rouault, Christine and Gautier, Emmanuel L and Oliveira, André Gustavo and Clément, Karine and Teixeira, Mauro Martins and Marcelin, Geneviève and Ferreira, Adaliene Versiani Matos},
  title = {TNF / TNFR1 is a Key Regulator of Prolonged Fasting‐Induced Decrease in Adipose Tissue},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202501928rr}
}
Kostenlos starten →